Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.1 USD | +3.52% |
|
+3.08% | +8.89% |
07-01 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
07-01 | Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from Russell Microcap Value Index | CI |
Evolution of the average Target Price on Kiniksa Pharmaceuticals International, plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kiniksa Pharmaceuticals International, plc
Wedbush | |
JPMorgan Chase | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- KNSA Stock
- Consensus Kiniksa Pharmaceuticals International, plc